SlideShare uma empresa Scribd logo
1 de 45
Gastric carcinoma
Lecture 9
GASTRIC ADENOCARCINOMA
Adenocarcinoma is the most common malignancy of the stomach, comprising over
90% -95% of all gastric cancers.
• Lymphomas 4%
• Carcinoid 3%
• Stromal tumors 2%
Epidemiology &
Classification
• GC is the second leading cause of cancer-related deaths in the world after lung cancer.
• In Japan, Chile, Costa Rica, and Eastern Europe the
incidence is up to 20-fold higher than in North America, northern Europe,
Africa, and Southeast Asia.
In the United States, gastric cancer rates dropped by
over 85% during the twentieth century. Similar declines have
been reported in many other Western countries, suggesting that
environmental and dietary
factors are responsible.
One possible explanation is
the decreased consumption of dietary carcinogens.
Intake of green, leafy vegetables and citrus fruits.
Gastric cancer is more common in
lower socioeconomic groups and in individuals with
multifocal mucosal atrophy and intestinal metaplasia.
• Although overall incidence of gastric
adenocarcinoma is falling,
•cancer of the
gastric cardia
is on the rise.
Classification:
GC show two morphologic types, called intestinal & diffuse.
I.The intestinal type
• arise from gastric mucous cells that have undergone intestinal metaplasia in the setting of chronic
gastritis.
• better differentiated
• the more common type in high risk populations.
• occurs primarily after age 50 years
• with a 2: 1 male predominance.
• The incidence of intestinal –type carcinoma has
progressively diminished in the US.
II.The diffuse variant
arise de novo from native gastric mucous cells, is
not associated with chronic gastritis,
poorly differentiated.
occurs at an earlier age
with female predominance.
The incidence of diffuse GA has not changed significantly in the past 60
years and now constitutes approximately half of gastric carcinomas in the
US.
• The intestinal and diffuse forms of gastric carcinomas can be considered as
distinct entities, although their clinical outcome is
similar.
The incidence of diffuse gastric cancer is relatively uniform
across countries, there are no identified precursor lesions, and
the disease occurs at similar frequencies in males and
females.
Risk Factors
• Gender -- men have more than double the risk of
getting stomach cancer than women.
• Race -- being African-American or Asian may
increase your risk.
• Genetics -- genetic abnormalities and some
inherited cancer syndromes may increase your risk
• Geography -- stomach cancer is more common in
Japan, the former Soviet Union, and parts of Central
America and South America.
• Blood type -- individuals with blood group A may be
at increased risk.
• Advanced age -- stomach cancer occurs more often
around ages 70 and 74 in men and women,
respectively.
• Family history of gastric cancer can double or triple the
risk of stomach cancer.
• Lifestyle factors such as smoking, drinking alcohol, and
eating a diet low in fruits and vegetables or high in
salted, smoked, or nitrate-preserved foods may
increase your risk
• Helicobacter pylori
• Certain health conditions including chronic gastritis,
pernicious anemia, gastric polyps, intestinal metaplasia,
and prior stomach surgery.
• Work-related exposure due to coal mining, nickel
refining, and rubber and timber processing and
asbestos exposure.
• Diffuse Carcinoma (Risk factors)
• Risk factors undefined, except for a rare inherited mutation of
E-cadherin
• Infection with H. pylori and chronic gastritis often absent
Pathogenesis
• The mechanisms of neoplastic transformation are not entirely clear.
• Chronic inflammation induced by H. pylori
• may release reactive oxygen species,
• which eventually cause DNA damage,
• leading to an imbalance between cell proliferation and apoptosis, particularly in areas of tissue repair.
Morphology
• The location of gastric carcinoma within the stomach is as follows:
• Pylorus and antrum, 50% to 60%;
• Cardia 25%; and
• the remainder (15-25%) in the body and
fundus.
• The lesser curvature is involved in about 40% and the
greater curvature in 12%.
• Thus, a favored location is
the lesser curvature of the antropyloric region.
Morphology cont.
• Though less frequent, an ulcerative lesion on the
greater curvature is more likely to be
malignant than benign.
Morphology cont.
• GC is classified on the basis of
• depth of invasion,
• Macroscopic growth pattern, and
• Histologic subtype.
Classification on the basis of depth of Invasion
• Early gastric carcinoma is defined as a lesion confined to the
mucosa and submucosa, regardless of the presence or absence of perigastric lymph node metastases.
Morphology cont.
Classification on the basis of depth of Invasion
• Advanced gastric carcinoma is a neoplasm that has extended
below the submucosa into the muscular wall
and has perhaps spread more widely.
Morphology
cont.
Morphology cont.
Gastric mucosal dysplasia is
the presumed precursor lesion of
early gastric cancer,
which then in turn progresses to advanced lesions.
•Part II
Classification on the basis of macroscopic growth patterns
• The three macroscopic growth patterns of gastric
carcinoma which may be evident at both the early and advanced stages, are
1.Exophyticwith protrusion of a tumor mass into the lumen;
2.Flat or depressed, in which there is no obvious tumor mass within the mucosa; and
3.Excavated, whereby a shallow or deeply erosive crater is present in the wall of the stomach.
Morphology cont.
Morphology cont.
• Exophytic tumors may contain portions of an
adenoma.
• Flat or depressed malignancy presents only as regional effacement
of the normal surface mucosal pattern.
• Excavated cancers may mimic, in size and
appearance, chronic peptic ulcers,
although more advanced cases show heaped-up
margins.
Classification on the basis of histology
intestinal
& diffuse.
Morphology cont.
Morphology cont.
The intestinal variant is composed of
malignant cells forming neoplastic
intestinal glands resembling
those of colonic adenocarcinoma.
• Gastric tumors with an intestinal
morphology tend to form
bulky tumors
Morphology cont.
• The diffuse variant is composed of
gastric –type mucous cells that
generally do not form glands but rather
permeate the mucosa and wall as scattered
individual
• signet-ring cells or
• small clusters in an infiltrative growth
pattern.
Morphology cont.
A mass may be difficult to appreciate in diffuse gastric cancer, but
these infiltrative tumors often evoke a
Desmoplastic
reaction that stiffens
the gastric wall and
may provide a valuable diagnostic clue.
Morphology cont.
The rigid and thickened stomach
is termed a leather bottle stomach, or linitis plastica
due to desmoplastic reaction ( in diffuse variant).
Brinton's disease
• Whatever the histologic variant, all gastric carcinomas eventually penetrate the wall to involve the
serosa,
spread to regional and more distant
lymph nodes, and
metastasize widely.
For obscure reasons, In advanced cases gastric carcinoma
the earliest lymph node metastasis
may sometimes involve a
Supraclavicular
lymph node
(Virchow node).
Rudolf Karl Virchow
Virchow- German pathologist
(1821-1902)
Gastric tumors can also metastasize to the periumbilical region
to form a subcutaneous nodule, termed a
Sister Mary Joseph nodule,
after the nurse who first noted this lesion as a marker of metastatic carcinoma.
• Another somewhat unusual mode of
intraperitoneal spread in females is to both
the ovaries, giving rise to the so called
Krukenburg tumor.
Local invasion into
the duodenum,
pancreas,
Retroperitoneum
Gastric adenocarcinoma. A, Intestinal-type adenocarcinoma consisting of an elevated
mass with heaped-up borders and central ulceration. B, Linitis plastica. The gastric
wall is markedly thickened, and rugal folds are partially lost.
Diffuse type
Clinical features
Early stage:
• Indigestion and stomach discomfort
• A bloated feeling after eating
• Mild nausea
• Loss of appetite
• Heartburn
Clinical features
Advanced stage:
• Discomfort in the upper or middle part of the
abdomen.
• Blood in the stool (which appears as black, tarry
stools).
• Vomiting or vomiting blood.
• Weight loss.
• Pain or bloating in the stomach after eating.
• Weakness or fatigue associated with mild anemia
(a deficiency in red blood cells).
Diagnosis
• Signs& symptoms
• Medical History & Physical exam
• Upper endoscopy
• Biopsy
• Testing Biopsy
• Imaging tests
• Endoscopic Ultrasound
• CT scan
• MRI
• PET
• Chest X-ray
• Laparoscopy
• Lab tests
Treatment
Chemotherapy or
radiation therapy and
palliative care.
However, when possible, surgical resection remains the preferred
treatment for gastric adenocarcinoma.
Prognosis
• After surgical resection, the 5-year survival
rate of early gastric cancer
can exceed 90%,
even if lymph node metastases are present.
Prognosis cont.
• In contrast, the 5-year survival rate for
advanced gastric cancer
remains
below 20%.
Prevention
General Measures
Screening
(Mass endoscopic screening programs)
The only hope for cure is early detection and
surgical removal, because the most important
prognostic indicator is stage of the tumor at the time of
resection.
L9 gastric carcinoma f

Mais conteúdo relacionado

Mais procurados

Carcinoma of the GI Tract
Carcinoma of the GI TractCarcinoma of the GI Tract
Carcinoma of the GI Tract
Patrick Carter
 

Mais procurados (20)

Esophageal ca
Esophageal caEsophageal ca
Esophageal ca
 
Carcinoma of Stomach
 Carcinoma of Stomach Carcinoma of Stomach
Carcinoma of Stomach
 
Renal Tumors, Renal Cell Carcinoma- Dr. Vandana
Renal Tumors, Renal Cell Carcinoma-  Dr. VandanaRenal Tumors, Renal Cell Carcinoma-  Dr. Vandana
Renal Tumors, Renal Cell Carcinoma- Dr. Vandana
 
Carcinoma rectum (Rectal Cancer)
Carcinoma rectum (Rectal Cancer)Carcinoma rectum (Rectal Cancer)
Carcinoma rectum (Rectal Cancer)
 
Gastric Cancer ( stomach tumor )
Gastric Cancer ( stomach tumor )Gastric Cancer ( stomach tumor )
Gastric Cancer ( stomach tumor )
 
Carcinoma of the GI Tract
Carcinoma of the GI TractCarcinoma of the GI Tract
Carcinoma of the GI Tract
 
PERI-AMPULLARY CARCINOMA
PERI-AMPULLARY CARCINOMAPERI-AMPULLARY CARCINOMA
PERI-AMPULLARY CARCINOMA
 
Pancreatic cancer
Pancreatic cancerPancreatic cancer
Pancreatic cancer
 
Esophageal cancer
Esophageal cancerEsophageal cancer
Esophageal cancer
 
Tumors of intestine
Tumors of intestineTumors of intestine
Tumors of intestine
 
Carcinoma oesophagus
Carcinoma oesophagusCarcinoma oesophagus
Carcinoma oesophagus
 
Bladder carcinoma
Bladder carcinomaBladder carcinoma
Bladder carcinoma
 
Intestinal polyps
Intestinal polypsIntestinal polyps
Intestinal polyps
 
Colorectal cancer
Colorectal  cancerColorectal  cancer
Colorectal cancer
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
 
CARCINOMA STOMACH
CARCINOMA STOMACHCARCINOMA STOMACH
CARCINOMA STOMACH
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
CARCINOMA STOMACH AETIOLOGY,CLASSIFICATION & CLINICAL FEATURES BY JOSE JAMES
CARCINOMA STOMACHAETIOLOGY,CLASSIFICATION & CLINICAL FEATURES BY JOSE JAMESCARCINOMA STOMACHAETIOLOGY,CLASSIFICATION & CLINICAL FEATURES BY JOSE JAMES
CARCINOMA STOMACH AETIOLOGY,CLASSIFICATION & CLINICAL FEATURES BY JOSE JAMES
 
Carcinoma of the pancreas
Carcinoma of the pancreasCarcinoma of the pancreas
Carcinoma of the pancreas
 
Stomach cancer
Stomach cancerStomach cancer
Stomach cancer
 

Destaque (9)

cancer stomach
cancer stomachcancer stomach
cancer stomach
 
Focal & segmental glomerulosclerosis
Focal & segmental glomerulosclerosisFocal & segmental glomerulosclerosis
Focal & segmental glomerulosclerosis
 
Intestinal obstruction
Intestinal obstructionIntestinal obstruction
Intestinal obstruction
 
11 esophageal cancer
11 esophageal cancer11 esophageal cancer
11 esophageal cancer
 
Carcinoma stomach
Carcinoma stomachCarcinoma stomach
Carcinoma stomach
 
L acute appendicitis
L acute appendicitisL acute appendicitis
L acute appendicitis
 
Glomerular diseases
Glomerular diseasesGlomerular diseases
Glomerular diseases
 
Intestinal obstruction
Intestinal obstructionIntestinal obstruction
Intestinal obstruction
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 

Semelhante a L9 gastric carcinoma f

CA Gall bladder ; AdenoCA Stomach
CA Gall bladder ; AdenoCA StomachCA Gall bladder ; AdenoCA Stomach
CA Gall bladder ; AdenoCA Stomach
Shahin Hameed
 
Esophageal Carcinoma
Esophageal CarcinomaEsophageal Carcinoma
Esophageal Carcinoma
bbxoxo
 

Semelhante a L9 gastric carcinoma f (20)

L9 gastric carcinoma f
L9 gastric carcinoma fL9 gastric carcinoma f
L9 gastric carcinoma f
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
CA Gall bladder ; AdenoCA Stomach
CA Gall bladder ; AdenoCA StomachCA Gall bladder ; AdenoCA Stomach
CA Gall bladder ; AdenoCA Stomach
 
COLORECTAL CANCER by Dr. Oyintonbra Koroye pptx
COLORECTAL CANCER by Dr. Oyintonbra Koroye pptxCOLORECTAL CANCER by Dr. Oyintonbra Koroye pptx
COLORECTAL CANCER by Dr. Oyintonbra Koroye pptx
 
Carcinoma stomach by Dr.K.AmrithaAnilkumar
Carcinoma stomach by Dr.K.AmrithaAnilkumarCarcinoma stomach by Dr.K.AmrithaAnilkumar
Carcinoma stomach by Dr.K.AmrithaAnilkumar
 
62167148 case-analysis-gastro
62167148 case-analysis-gastro62167148 case-analysis-gastro
62167148 case-analysis-gastro
 
L5,l6 esophageal tumors
L5,l6  esophageal tumorsL5,l6  esophageal tumors
L5,l6 esophageal tumors
 
Colon cancer
Colon cancer Colon cancer
Colon cancer
 
Carcinoma stomach- A Brief Overview- Part 1
Carcinoma stomach- A Brief Overview- Part 1Carcinoma stomach- A Brief Overview- Part 1
Carcinoma stomach- A Brief Overview- Part 1
 
Colorectal Cancer
Colorectal CancerColorectal Cancer
Colorectal Cancer
 
Gastric ca
Gastric caGastric ca
Gastric ca
 
Colon cancer final
Colon cancer finalColon cancer final
Colon cancer final
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
Seminar on gastric cancer
Seminar on gastric cancerSeminar on gastric cancer
Seminar on gastric cancer
 
colon cancer, 7 final.pptx
colon cancer, 7 final.pptxcolon cancer, 7 final.pptx
colon cancer, 7 final.pptx
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
Esophageal Carcinoma
Esophageal CarcinomaEsophageal Carcinoma
Esophageal Carcinoma
 
GIT malignancies
GIT malignanciesGIT malignancies
GIT malignancies
 
Carcinoma Colon (large intestine ).pptx
Carcinoma Colon (large intestine  ).pptxCarcinoma Colon (large intestine  ).pptx
Carcinoma Colon (large intestine ).pptx
 
Pancreatic-Cancer.ppt presentation for med Surg
Pancreatic-Cancer.ppt presentation for med SurgPancreatic-Cancer.ppt presentation for med Surg
Pancreatic-Cancer.ppt presentation for med Surg
 

Mais de Mohammad Manzoor

L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis students
Mohammad Manzoor
 
L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis students
Mohammad Manzoor
 
L29 hepatocellular carcinoma
L29 hepatocellular carcinomaL29 hepatocellular carcinoma
L29 hepatocellular carcinoma
Mohammad Manzoor
 

Mais de Mohammad Manzoor (20)

Chronic cholecystitis practical
Chronic cholecystitis practicalChronic cholecystitis practical
Chronic cholecystitis practical
 
L cholecystitis students
L cholecystitis studentsL cholecystitis students
L cholecystitis students
 
L acute appendicitis
L acute appendicitisL acute appendicitis
L acute appendicitis
 
Granuloma lecture st
Granuloma lecture stGranuloma lecture st
Granuloma lecture st
 
Prostate
ProstateProstate
Prostate
 
Granulation tissue formation
Granulation tissue formationGranulation tissue formation
Granulation tissue formation
 
Fatty liver
Fatty liverFatty liver
Fatty liver
 
Tissue processing by dr manzoor
Tissue processing by dr manzoorTissue processing by dr manzoor
Tissue processing by dr manzoor
 
Liver cirrhosis for students n
Liver cirrhosis for students nLiver cirrhosis for students n
Liver cirrhosis for students n
 
Skin cancer
Skin cancerSkin cancer
Skin cancer
 
Lipoma by manzoor
Lipoma by manzoorLipoma by manzoor
Lipoma by manzoor
 
L1 nomenclature of tumors
L1 nomenclature of tumorsL1 nomenclature of tumors
L1 nomenclature of tumors
 
Characteristics of neoplasms
Characteristics of neoplasmsCharacteristics of neoplasms
Characteristics of neoplasms
 
Endometrial polyp, hyperplasia, carcinoma
Endometrial polyp, hyperplasia, carcinomaEndometrial polyp, hyperplasia, carcinoma
Endometrial polyp, hyperplasia, carcinoma
 
Non neoplastic disorders of endometrium
Non neoplastic disorders of endometriumNon neoplastic disorders of endometrium
Non neoplastic disorders of endometrium
 
Esophageal disorders
Esophageal disordersEsophageal disorders
Esophageal disorders
 
L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis students
 
L31 cholecystitis students
L31 cholecystitis studentsL31 cholecystitis students
L31 cholecystitis students
 
L30 gallstones student
L30 gallstones studentL30 gallstones student
L30 gallstones student
 
L29 hepatocellular carcinoma
L29 hepatocellular carcinomaL29 hepatocellular carcinoma
L29 hepatocellular carcinoma
 

Último

Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
Naveen Gokul Dr
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
JRRolfNeuqelet
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 

Último (20)

Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalVaricose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
^In Pietermaritzburg Hager Werken Embalming +27789155305 Compound Powder in ...
^In Pietermaritzburg  Hager Werken Embalming +27789155305 Compound Powder in ...^In Pietermaritzburg  Hager Werken Embalming +27789155305 Compound Powder in ...
^In Pietermaritzburg Hager Werken Embalming +27789155305 Compound Powder in ...
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
Tips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in IndoreTips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in Indore
 
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
 
Post-Cycle Therapy (PCT) in bodybuilding docx.pdf
Post-Cycle Therapy (PCT) in bodybuilding  docx.pdfPost-Cycle Therapy (PCT) in bodybuilding  docx.pdf
Post-Cycle Therapy (PCT) in bodybuilding docx.pdf
 
Gait deviations in Transtibial prosthesis users
Gait deviations in Transtibial prosthesis usersGait deviations in Transtibial prosthesis users
Gait deviations in Transtibial prosthesis users
 

L9 gastric carcinoma f

  • 2. GASTRIC ADENOCARCINOMA Adenocarcinoma is the most common malignancy of the stomach, comprising over 90% -95% of all gastric cancers. • Lymphomas 4% • Carcinoid 3% • Stromal tumors 2%
  • 3. Epidemiology & Classification • GC is the second leading cause of cancer-related deaths in the world after lung cancer. • In Japan, Chile, Costa Rica, and Eastern Europe the incidence is up to 20-fold higher than in North America, northern Europe, Africa, and Southeast Asia.
  • 4. In the United States, gastric cancer rates dropped by over 85% during the twentieth century. Similar declines have been reported in many other Western countries, suggesting that environmental and dietary factors are responsible. One possible explanation is the decreased consumption of dietary carcinogens. Intake of green, leafy vegetables and citrus fruits.
  • 5. Gastric cancer is more common in lower socioeconomic groups and in individuals with multifocal mucosal atrophy and intestinal metaplasia.
  • 6. • Although overall incidence of gastric adenocarcinoma is falling, •cancer of the gastric cardia is on the rise.
  • 7. Classification: GC show two morphologic types, called intestinal & diffuse. I.The intestinal type • arise from gastric mucous cells that have undergone intestinal metaplasia in the setting of chronic gastritis. • better differentiated • the more common type in high risk populations.
  • 8. • occurs primarily after age 50 years • with a 2: 1 male predominance. • The incidence of intestinal –type carcinoma has progressively diminished in the US.
  • 9. II.The diffuse variant arise de novo from native gastric mucous cells, is not associated with chronic gastritis, poorly differentiated. occurs at an earlier age with female predominance. The incidence of diffuse GA has not changed significantly in the past 60 years and now constitutes approximately half of gastric carcinomas in the US.
  • 10. • The intestinal and diffuse forms of gastric carcinomas can be considered as distinct entities, although their clinical outcome is similar.
  • 11. The incidence of diffuse gastric cancer is relatively uniform across countries, there are no identified precursor lesions, and the disease occurs at similar frequencies in males and females.
  • 12. Risk Factors • Gender -- men have more than double the risk of getting stomach cancer than women. • Race -- being African-American or Asian may increase your risk. • Genetics -- genetic abnormalities and some inherited cancer syndromes may increase your risk • Geography -- stomach cancer is more common in Japan, the former Soviet Union, and parts of Central America and South America. • Blood type -- individuals with blood group A may be at increased risk.
  • 13. • Advanced age -- stomach cancer occurs more often around ages 70 and 74 in men and women, respectively. • Family history of gastric cancer can double or triple the risk of stomach cancer. • Lifestyle factors such as smoking, drinking alcohol, and eating a diet low in fruits and vegetables or high in salted, smoked, or nitrate-preserved foods may increase your risk • Helicobacter pylori • Certain health conditions including chronic gastritis, pernicious anemia, gastric polyps, intestinal metaplasia, and prior stomach surgery. • Work-related exposure due to coal mining, nickel refining, and rubber and timber processing and asbestos exposure.
  • 14. • Diffuse Carcinoma (Risk factors) • Risk factors undefined, except for a rare inherited mutation of E-cadherin • Infection with H. pylori and chronic gastritis often absent
  • 15. Pathogenesis • The mechanisms of neoplastic transformation are not entirely clear. • Chronic inflammation induced by H. pylori • may release reactive oxygen species, • which eventually cause DNA damage, • leading to an imbalance between cell proliferation and apoptosis, particularly in areas of tissue repair.
  • 16. Morphology • The location of gastric carcinoma within the stomach is as follows: • Pylorus and antrum, 50% to 60%; • Cardia 25%; and • the remainder (15-25%) in the body and fundus. • The lesser curvature is involved in about 40% and the greater curvature in 12%. • Thus, a favored location is the lesser curvature of the antropyloric region.
  • 17. Morphology cont. • Though less frequent, an ulcerative lesion on the greater curvature is more likely to be malignant than benign.
  • 18. Morphology cont. • GC is classified on the basis of • depth of invasion, • Macroscopic growth pattern, and • Histologic subtype.
  • 19. Classification on the basis of depth of Invasion • Early gastric carcinoma is defined as a lesion confined to the mucosa and submucosa, regardless of the presence or absence of perigastric lymph node metastases. Morphology cont.
  • 20. Classification on the basis of depth of Invasion • Advanced gastric carcinoma is a neoplasm that has extended below the submucosa into the muscular wall and has perhaps spread more widely. Morphology cont.
  • 21. Morphology cont. Gastric mucosal dysplasia is the presumed precursor lesion of early gastric cancer, which then in turn progresses to advanced lesions.
  • 23. Classification on the basis of macroscopic growth patterns • The three macroscopic growth patterns of gastric carcinoma which may be evident at both the early and advanced stages, are 1.Exophyticwith protrusion of a tumor mass into the lumen; 2.Flat or depressed, in which there is no obvious tumor mass within the mucosa; and 3.Excavated, whereby a shallow or deeply erosive crater is present in the wall of the stomach. Morphology cont.
  • 24. Morphology cont. • Exophytic tumors may contain portions of an adenoma. • Flat or depressed malignancy presents only as regional effacement of the normal surface mucosal pattern. • Excavated cancers may mimic, in size and appearance, chronic peptic ulcers, although more advanced cases show heaped-up margins.
  • 25. Classification on the basis of histology intestinal & diffuse. Morphology cont.
  • 26. Morphology cont. The intestinal variant is composed of malignant cells forming neoplastic intestinal glands resembling those of colonic adenocarcinoma.
  • 27. • Gastric tumors with an intestinal morphology tend to form bulky tumors
  • 28. Morphology cont. • The diffuse variant is composed of gastric –type mucous cells that generally do not form glands but rather permeate the mucosa and wall as scattered individual • signet-ring cells or • small clusters in an infiltrative growth pattern.
  • 29. Morphology cont. A mass may be difficult to appreciate in diffuse gastric cancer, but these infiltrative tumors often evoke a Desmoplastic reaction that stiffens the gastric wall and may provide a valuable diagnostic clue.
  • 30. Morphology cont. The rigid and thickened stomach is termed a leather bottle stomach, or linitis plastica due to desmoplastic reaction ( in diffuse variant). Brinton's disease
  • 31. • Whatever the histologic variant, all gastric carcinomas eventually penetrate the wall to involve the serosa, spread to regional and more distant lymph nodes, and metastasize widely.
  • 32. For obscure reasons, In advanced cases gastric carcinoma the earliest lymph node metastasis may sometimes involve a Supraclavicular lymph node (Virchow node).
  • 33. Rudolf Karl Virchow Virchow- German pathologist (1821-1902)
  • 34. Gastric tumors can also metastasize to the periumbilical region to form a subcutaneous nodule, termed a Sister Mary Joseph nodule, after the nurse who first noted this lesion as a marker of metastatic carcinoma.
  • 35. • Another somewhat unusual mode of intraperitoneal spread in females is to both the ovaries, giving rise to the so called Krukenburg tumor.
  • 36. Local invasion into the duodenum, pancreas, Retroperitoneum
  • 37. Gastric adenocarcinoma. A, Intestinal-type adenocarcinoma consisting of an elevated mass with heaped-up borders and central ulceration. B, Linitis plastica. The gastric wall is markedly thickened, and rugal folds are partially lost. Diffuse type
  • 38. Clinical features Early stage: • Indigestion and stomach discomfort • A bloated feeling after eating • Mild nausea • Loss of appetite • Heartburn
  • 39. Clinical features Advanced stage: • Discomfort in the upper or middle part of the abdomen. • Blood in the stool (which appears as black, tarry stools). • Vomiting or vomiting blood. • Weight loss. • Pain or bloating in the stomach after eating. • Weakness or fatigue associated with mild anemia (a deficiency in red blood cells).
  • 40. Diagnosis • Signs& symptoms • Medical History & Physical exam • Upper endoscopy • Biopsy • Testing Biopsy • Imaging tests • Endoscopic Ultrasound • CT scan • MRI • PET • Chest X-ray • Laparoscopy • Lab tests
  • 41. Treatment Chemotherapy or radiation therapy and palliative care. However, when possible, surgical resection remains the preferred treatment for gastric adenocarcinoma.
  • 42. Prognosis • After surgical resection, the 5-year survival rate of early gastric cancer can exceed 90%, even if lymph node metastases are present.
  • 43. Prognosis cont. • In contrast, the 5-year survival rate for advanced gastric cancer remains below 20%.
  • 44. Prevention General Measures Screening (Mass endoscopic screening programs) The only hope for cure is early detection and surgical removal, because the most important prognostic indicator is stage of the tumor at the time of resection.